01IMMEDIATE ACTION REQUIRED - By July 1, 2026.
02Billing team must update billing system to TERMINATE all claims for codes G0434, G0434 HF, G0434 QW, G0482, G0483, 80102, 80102 HF, 80104, 80104 HF, and 80104 QW - these will be denied if submitted.
03Re-activate G0481 billing for any authorized provider; activate G0481HF ONLY for SUD Outpatient Treatment Providers.
04Implement system edits to enforce utilization limits: Presumptive drug tests (80305, 80306, 80307 and HF variants) = maximum 1 per date of service AND 10 per rolling 28 days; Definitive drug tests (G0480, G0481 and HF variants) = maximum 2 per rolling 28 days.
05Configure system to deny definitive drug test claims (G0480, G0481) unless a paid presumptive test claim exists for same date or within 7 days prior.
06Update provider/lab education materials to restrict definitive testing only when: patient disputes result, specific substance detection needed, substance not identified by presumptive methods, or results inform major clinical decisions.
07Deny payment for CPT codes 84311, 83986, 82570, 83789, 84315 when billed same date as presumptive/definitive drug tests.
08Implement post-payment audit protocols to flag inappropriate billing.
09Redirect all managed care members' drug testing claims to their managed care plan effective July 1, 2026; continue FFS submissions through Gainwell only for non-managed care members.
10Educate providers that 'blanket orders' (identical tests for all patients) are not covered; only 'standing orders' based on evidence protocols, patient-specific, updated annually, and effective no longer than 12 months are allowed.